These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 2141040

  • 1. A study of in vivo immune complex formation and clearance in man.
    Davies KA, Hird V, Stewart S, Sivolapenko GB, Jose P, Epenetos AA, Walport MJ.
    J Immunol; 1990 Jun 15; 144(12):4613-20. PubMed ID: 2141040
    [Abstract] [Full Text] [Related]

  • 2. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms.
    Schifferli JA, Ng YC, Estreicher J, Walport MJ.
    J Immunol; 1988 Feb 01; 140(3):899-904. PubMed ID: 2963069
    [Abstract] [Full Text] [Related]

  • 3. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
    Schifferli JA, Ng YC, Paccaud JP, Walport MJ.
    Clin Exp Immunol; 1989 Mar 01; 75(3):329-35. PubMed ID: 2522842
    [Abstract] [Full Text] [Related]

  • 4. Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells.
    Emlen W, Burdick G, Carl V, Lachmann PJ.
    J Immunol; 1989 Jun 15; 142(12):4366-71. PubMed ID: 2524529
    [Abstract] [Full Text] [Related]

  • 5. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
    Craig ML, Bankovich AJ, McElhenny JL, Taylor RP.
    Arthritis Rheum; 2000 Oct 15; 43(10):2265-75. PubMed ID: 11037886
    [Abstract] [Full Text] [Related]

  • 6. Clearance of 131I-labeled murine monoclonal antibody from patients' blood by intravenous human anti-murine immunoglobulin antibody.
    Stewart JS, Sivolapenko GB, Hird V, Davies KA, Walport M, Ritter MA, Epenetos AA.
    Cancer Res; 1990 Feb 01; 50(3):563-7. PubMed ID: 2297697
    [Abstract] [Full Text] [Related]

  • 7. Cross-linked bispecific monoclonal antibody heteropolymers facilitate the clearance of human IgM from the circulation of squirrel monkeys.
    Reist CJ, Liang HY, Denny D, Martin EN, Scheld WM, Taylor RP.
    Eur J Immunol; 1994 Sep 01; 24(9):2018-25. PubMed ID: 8088321
    [Abstract] [Full Text] [Related]

  • 8. Immune adherence of nascent hepatitis B surface antigen-antibody complexes in vivo in humans.
    Madi N, Paccaud JP, Steiger G, Schifferli JA.
    Clin Exp Immunol; 1989 Nov 01; 78(2):201-6. PubMed ID: 12412749
    [Abstract] [Full Text] [Related]

  • 9. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD, Yount WJ, Walport MJ, Winfield JB, Parker CJ, Fuller CR, Taylor RP, Myones BL, Lachmann PJ.
    J Immunol; 1985 Sep 01; 135(3):2005-14. PubMed ID: 4020137
    [Abstract] [Full Text] [Related]

  • 10. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
    Marzocchi-Machado CM, Alves CM, Azzolini AE, Polizello AC, Carvalho IF, Lucisano-Valim YM.
    J Autoimmun; 2005 Dec 01; 25(4):289-97. PubMed ID: 16289666
    [Abstract] [Full Text] [Related]

  • 11. Abnormal immune adherence and elimination of hepatitis B surface antigen/antibody complexes in patients with AIDS.
    Madi N, Steiger G, Estreicher J, Schifferli JA.
    J Immunol; 1992 Feb 01; 148(3):723-8. PubMed ID: 1530955
    [Abstract] [Full Text] [Related]

  • 12. Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria.
    Roberts WN, Wilson JG, Wong W, Jenkins DE, Fearon DT, Austen KF, Nicholson-Weller A.
    J Immunol; 1985 Jan 01; 134(1):512-7. PubMed ID: 2578050
    [Abstract] [Full Text] [Related]

  • 13. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
    Tas SW, Klickstein LB, Barbashov SF, Nicholson-Weller A.
    J Immunol; 1999 Nov 01; 163(9):5056-63. PubMed ID: 10528211
    [Abstract] [Full Text] [Related]

  • 14. C3, C4, and the terminal complement complex differ from C1q by binding predominantly to the antigenic part of solid phase immune complexes.
    Garred P, Michaelsen TE, Aase A, Mollnes TE.
    J Immunol; 1990 Jan 01; 144(1):198-203. PubMed ID: 2295791
    [Abstract] [Full Text] [Related]

  • 15. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
    Ng YC, Schifferli JA, Walport MJ.
    Clin Exp Immunol; 1988 Mar 01; 71(3):481-5. PubMed ID: 2968204
    [Abstract] [Full Text] [Related]

  • 16. Splenic uptake of immune complexes in man is complement-dependent.
    Davies KA, Erlendsson K, Beynon HL, Peters AM, Steinsson K, Valdimarsson H, Walport MJ.
    J Immunol; 1993 Oct 01; 151(7):3866-73. PubMed ID: 8376807
    [Abstract] [Full Text] [Related]

  • 17. Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia.
    Corvetta A, Spaeth PJ, Ghirelli PA, Orecchioni F, Buetler R, Montroni M, Nydegger UE.
    Diagn Immunol; 1983 Oct 01; 1(4):315-23. PubMed ID: 6333960
    [Abstract] [Full Text] [Related]

  • 18. Immune complex erythrocyte complement receptor interactions in vivo during induction of glomerulonephritis in nonhuman primates.
    Birmingham DJ, Hebert LA, Cosio FG, VanAman ME.
    J Lab Clin Med; 1990 Aug 01; 116(2):242-52. PubMed ID: 1697615
    [Abstract] [Full Text] [Related]

  • 19. Low expression of erythrocyte complement receptor type 1 in chronic hepatitis C patients.
    Kanto T, Hayashi N, Takehara T, Katayama K, Kato M, Akiyama M, Kasahara A, Fusamoto H, Kamada T.
    J Med Virol; 1996 Oct 01; 50(2):126-34. PubMed ID: 8915878
    [Abstract] [Full Text] [Related]

  • 20. The blockade of Fc receptor-mediated clearance of immune complexes in vivo by a monoclonal antibody (2.4G2) directed against Fc receptors on murine leukocytes.
    Kurlander RJ, Ellison DM, Hall J.
    J Immunol; 1984 Aug 01; 133(2):855-62. PubMed ID: 6736648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.